Zai Lab (ZLAB) EBIAT (2020 - 2025)
Zai Lab (ZLAB) has disclosed EBIAT for 6 consecutive years, with -$50.4 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 38.29% to -$50.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$175.5 million through Dec 2025, up 31.73% year-over-year, with the annual reading at -$175.5 million for FY2025, 31.73% up from the prior year.
- EBIAT hit -$50.4 million in Q4 2025 for Zai Lab, down from -$36.0 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$36.0 million in Q3 2025 to a low of -$232.9 million in Q1 2021.
- Historically, EBIAT has averaged -$95.8 million across 5 years, with a median of -$81.0 million in 2024.
- Biggest five-year swings in EBIAT: tumbled 385.35% in 2021 and later skyrocketed 70.84% in 2022.
- Year by year, EBIAT stood at -$211.8 million in 2021, then surged by 70.84% to -$61.8 million in 2022, then tumbled by 54.49% to -$95.4 million in 2023, then increased by 14.4% to -$81.7 million in 2024, then surged by 38.29% to -$50.4 million in 2025.
- Business Quant data shows EBIAT for ZLAB at -$50.4 million in Q4 2025, -$36.0 million in Q3 2025, and -$40.7 million in Q2 2025.